Brief: Lonza Expands Dual-Payload ADC Technology Offering Through Access To Qurient's CDK7 Inhibitors
12/10/2026 13:04
BRIEF-Lonza Expands Dual-Payload ADC Technology Offering Through Access To Qurient's CDK7 Inhibitors Oct 12 (Reuters) - LONZA GROUP AG LONN.S:
EXPANDS DUAL-PAYLOAD ADC TECHNOLOGY OFFERING THROUGH EXCLUSIVE ACCESS TO QURIENT'S CDK7 INHIBITORS
Source text: ID:nEQ5Qtjp1a
Further company coverage: LONN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Lonza AG
See all newsLonza buys 5 sites from Germany's Merck to more than double US footprint (updated)
Brief: Merck KGaA Confirms Divestment Of CDMO Business To Lonza
Lonza agrees to buy five US sites from Merck KGaA
Corrected: TABLE-Swiss trade surplus at CHF 4.35 bln in August (Sept. 17)
Table: Swiss trade surplus at CHF 1.31 bln in September